Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders

Botulinum toxin A (BoNT-A) intravesical injections have been used to treat patients with refractory functional bladder disorders such as overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS), but the risk of adverse events and the need for repeated injections continue to...

Full description

Bibliographic Details
Published in:Toxins
Main Authors: Fan-Ching Hung, Hann-Chorng Kuo
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Subjects:
botulinum toxin A
liposome
bladder oversensitivity
interstitial cystitis
detrusor overactivity
Online Access:https://www.mdpi.com/2072-6651/14/12/838

Internet

https://www.mdpi.com/2072-6651/14/12/838

Similar Items